Lorena Fiad

1PUBLICATIONS
9CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (1)

Sort by Publication Date:
|Aug 09, 2026
Long-term follow-up of PET/CT-adapted therapy after three cycles of ABVD for all stages of classic Hodgkin lymphoma: Results of the GATLA LH-05 trial.

Pageof 1

Frequent Collaborators

1 joint publications

Astrid Pavlovsky

1 joint publications

Isolda Fernández

1 joint publications

Amalia Cerutti

1 joint publications

Guillermina Remaggi

1 joint publications

Luciana Ferrari

1 joint publications

Luciana Guanchiale

1 joint publications

Romina Mariano

1 joint publications

Gonzalo Bentolila

1 joint publications

Fernando Warley

Frequent Collaborators

1 joint publications

Astrid Pavlovsky

1 joint publications

Isolda Fernández

1 joint publications

Amalia Cerutti

1 joint publications

Guillermina Remaggi

JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
Jove
Visualize
Contact Us

Top Related Videos

Murine Lymphocyte Labeling by <sup>64</sup>Cu-Antibody Receptor Targeting for <em>In Vivo </em> Cell Trafficking by PET/CT
11:34

Murine Lymphocyte Labeling by <sup>64</sup>Cu-Antibody Receptor Targeting for <em>In Vivo </em> Cell Trafficking by PET/CT

Published on : Apr 29, 2017

See more related videos

Top Related Videos

Murine Lymphocyte Labeling by <sup>64</sup>Cu-Antibody Receptor Targeting for <em>In Vivo </em> Cell Trafficking by PET/CT
11:34

Murine Lymphocyte Labeling by <sup>64</sup>Cu-Antibody Receptor Targeting for <em>In Vivo </em> Cell Trafficking by PET/CT

Published on : Apr 29, 2017

See more related videos